However, the roles of ALKBH5 in glioblastoma stemness are independent from GCLM, because modulating GCLM expression using shRNAs or an inhibitor did not significantly impact the levels of GSC stemness markers or self-renewal [44]. Here, ALKBH5 is linked to glioblastoma.